Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Canandaigua › NPI 1194776351
Hospital

The Frederick Ferris Thompson Hospital

The Frederick Ferris Thompson Hospital was paid $23.75M by Medicaid between Jan 2018 and Dec 2024, across 262 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.

33Billing provider infoTHE FREDERICK FERRIS THOMPSON HOSPITAL
CANANDAIGUA, NY 14424
33aNPI1194776351assigned 05/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.75M
24GClaims495,805
24DCodes billed262
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#56 of 231
Median peer was paid$561K
This provider vs. median42×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018939$51K
201926,523$1.44M
202076,914$3.64M
2021101,645$4.57M
2022102,657$5.11M
2023105,647$5.04M
2024incomplete81,480$3.91M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 17% 39,249 37,122 $3.92M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 11% 24,466 23,604 $2.54M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.7% 14,711 13,174 $2.30M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.7% 9,872 9,214 $1.59M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 5.3% 18,040 17,447 $1.26M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.8% 19,078 7,000 $913K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.7% 3,299 3,244 $889K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.7% 4,391 4,123 $631K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.4% 817 809 $566K
87631 2.1% 9,275 9,170 $505K
70450 Computed tomography, head or brain; without contrast material 2.0% 1,664 1,634 $479K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 3,041 2,910 $444K
250 more codes
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.8% 2,364 $426K
80053 Comprehensive metabolic panel 1.8% 25,067 $422K
99214 Doctor's office visit, returning patient (more involved) 1.3% 4,071 $310K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.1% 11,822 $264K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1.1% 207 $260K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 830 $232K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 7,084 $209K
96361 Intravenous infusion, hydration; each additional hour <1% 967 $206K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 257 $182K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,737 $174K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,351 $162K
97162 <1% 1,547 $160K
76770 <1% 935 $150K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,353 $146K
36415 Collection of venous blood by venipuncture <1% 24,493 $145K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,211 $134K
G0378 Hospital observation service, per hour <1% 512 $126K
71275 Computed tomographic angiography, chest, with contrast material <1% 383 $124K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 3,674 $108K
84443 Thyroid stimulating hormone (TSH) <1% 9,798 $106K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,291 $104K
97161 <1% 1,184 $99K
80048 Basic metabolic panel (calcium, ionized) <1% 6,928 $99K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,564 $95K
76801 <1% 1,687 $89K
80061 Lipid panel <1% 7,273 $88K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,540 $87K
76830 Ultrasound, transvaginal <1% 2,034 $85K
84439 <1% 6,992 $83K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,073 $80K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,476 $80K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,991 $79K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 236 $71K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,492 $69K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 2,632 $69K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 196 $67K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,536 $64K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 207 $63K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,783 $61K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,084 $60K
71046 Radiologic examination, chest; 2 views <1% 3,011 $56K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 987 $55K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,314 $51K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 347 $51K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,257 $50K
86850 <1% 2,599 $48K
87480 <1% 2,608 $44K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 975 $44K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,561 $43K
87510 <1% 2,545 $43K
59025 Fetal non-stress test <1% 770 $42K
84702 <1% 2,317 $40K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,923 $39K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 377 $38K
83880 <1% 1,142 $37K
86803 <1% 2,726 $36K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 207 $36K
87660 <1% 2,099 $35K
83036 Hemoglobin; glycosylated (A1C) <1% 3,695 $31K
86780 <1% 2,888 $31K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,713 $31K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,931 $31K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,021 $30K
86901 <1% 2,656 $29K
97535 Self-care/home management training, each 15 minutes <1% 760 $28K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,980 $27K
82607 <1% 2,190 $27K
87340 <1% 2,310 $25K
82728 <1% 1,910 $25K
86900 <1% 2,665 $25K
85027 <1% 7,522 $24K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 915 $24K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,426 $23K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 490 $22K
83655 <1% 1,496 $21K
87081 <1% 4,960 $20K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 561 $19K
76642 <1% 888 $19K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 27 $18K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,082 $17K
90715 <1% 652 $16K
71250 <1% 170 $16K
0012A <1% 489 $16K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,008 $15K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 24 $15K
86787 <1% 1,084 $15K
83735 <1% 2,262 $14K
82784 <1% 993 $13K
83970 <1% 259 $13K
86762 <1% 1,276 $12K
82043 <1% 882 $12K
93971 <1% 120 $12K
81025 <1% 3,286 $11K
97113 <1% 252 $11K
83550 <1% 1,139 $11K
0011A <1% 511 $11K
70551 Magnetic resonance imaging, brain; without contrast material <1% 36 $11K
71271 <1% 490 $11K
84403 <1% 342 $11K
82570 <1% 1,942 $10K
86140 <1% 2,442 $10K
74018 <1% 726 $10K
97165 <1% 129 $10K
80306 <1% 1,115 $10K
71045 Radiologic examination, chest; single view <1% 497 $10K
83540 <1% 1,876 $9K
83516 <1% 465 $9K
87150 <1% 351 $9K
83690 <1% 2,611 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,125 $9K
85610 <1% 2,368 $8K
87158 <1% 1,805 $8K
73130 <1% 245 $8K
80076 <1% 1,129 $8K
85380 <1% 351 $8K
77066 Tomosynthesis, mammo <1% 130 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 1,680 $7K
86038 <1% 696 $7K
A9576 Injection, gadoteridol, (prohance multipack), per ml <1% 354 $7K
73630 <1% 334 $7K
81001 <1% 3,254 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 141 $7K
87641 <1% 179 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 173 $7K
85652 <1% 2,801 $7K
82746 <1% 487 $7K
82565 <1% 1,554 $6K
73610 <1% 257 $6K
87186 <1% 1,019 $6K
76536 <1% 213 $6K
97035 <1% 358 $6K
86364 <1% 755 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 388 $6K
82950 <1% 1,372 $6K
84460 <1% 1,452 $6K
77065 Tomosynthesis, mammo <1% 90 $6K
86706 <1% 452 $6K
0002A <1% 200 $5K
86618 <1% 311 $5K
73110 <1% 90 $5K
86704 <1% 405 $5K
90686 <1% 281 $5K
84450 <1% 1,128 $5K
88304 <1% 74 $5K
94729 <1% 205 $5K
84703 <1% 1,510 $4K
73562 <1% 151 $4K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 26 $4K
84480 <1% 304 $4K
84156 <1% 1,084 $4K
82150 <1% 718 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 248 $4K
G0008 Administration of influenza virus vaccine <1% 243 $4K
A9573 Injection, gadopiclenol, 1 ml <1% 93 $4K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 39 $4K
72141 <1% 16 $4K
82977 <1% 793 $4K
0001A <1% 203 $4K
84520 <1% 1,005 $4K
70491 <1% 14 $4K
84132 <1% 789 $4K
99442 <1% 41 $4K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 142 $3K
80050 General health panel <1% 134 $3K
94010 <1% 84 $3K
70498 <1% 12 $3K
86376 <1% 129 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 342 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,280 $3K
84100 <1% 738 $2K
84295 <1% 851 $2K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 212 $2K
84146 <1% 121 $2K
84484 <1% 790 $2K
82247 <1% 709 $2K
85007 <1% 859 $2K
83001 <1% 140 $2K
99443 <1% 49 $2K
73140 <1% 31 $2K
83605 <1% 463 $2K
81003 <1% 1,480 $2K
87040 <1% 133 $2K
97116 <1% 71 $2K
84075 <1% 502 $2K
0071A <1% 43 $2K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 27 $2K
82040 <1% 466 $2K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 1,479 $2K
82947 <1% 555 $1K
84466 <1% 76 $1K
72125 Computed tomography, cervical spine; without contrast material <1% 13 $1K
80069 <1% 149 $1K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 13 $1K
81002 <1% 821 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 454 $1K
87505 <1% 15 $1K
0072A <1% 27 $1K
85730 <1% 260 $1K
87070 <1% 124 $1K
73030 <1% 55 $989.09
82670 <1% 41 $969.80
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 849 $939.60
86480 <1% 12 $899.50
84550 <1% 197 $836.89
J2704 Injection, propofol, 10 mg <1% 1,186 $808.44
94060 <1% 24 $799.07
86800 <1% 65 $787.97
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,551 $686.78
J2270 Injection, morphine sulfate, up to 10 mg <1% 114 $542.22
83020 <1% 40 $541.86
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,127 $538.25
99203 Doctor's office visit, new patient (routine) <1% 12 $530.98
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 61 $467.47
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,586 $398.01
99335 <1% 14 $374.91
90460 Immunization administration through 18 years of age via any route, first or only component <1% 16 $367.64
90472 Immunization administration, each additional vaccine (list separately) <1% 26 $366.15
86431 <1% 64 $355.98
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,485 $313.74
76813 <1% 13 $280.80
72100 <1% 40 $276.50
82533 <1% 17 $273.82
J1030 Injection, methylprednisolone acetate, 40 mg <1% 30 $261.87
86696 <1% 12 $243.23
83615 <1% 45 $226.21
72110 <1% 12 $218.16
J0690 Injection, cefazolin sodium, 500 mg <1% 144 $207.64
84481 <1% 12 $205.60
86231 <1% 12 $168.57
82951 <1% 12 $163.32
82550 <1% 32 $153.66
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 115 $138.73
87205 <1% 46 $125.30
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 16 $121.14
72070 <1% 13 $99.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 40 $84.38
J0780 Injection, prochlorperazine, up to 10 mg <1% 12 $64.17
86308 <1% 12 $60.60
J2550 Injection, promethazine hcl, up to 50 mg <1% 73 $54.34
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 237 $51.83
82248 <1% 14 $44.12
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 20 $41.38
82952 <1% 12 $33.36
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 43 $32.36
84155 <1% 12 $30.55
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 92 $29.04
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 12 $19.26
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 107 $14.64
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 37 $6.11
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 14 $0.71

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSTAPLETON, MICHAEL (PRESIDENT/CEO)
Same official

Other billing entities under STAPLETON, MICHAEL

Full network →
ProviderLocationPaid
Frederick Ferris Thompson HospitalCanandaigua, NY$4.75M
Frederick Ferris Thompson HospitalCanandaigua, NY$40K
Frederick Ferris Thompson HospitalCanandaigua, NY$24K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.